| Rivaroxaban |
|
| (CAS 366789-02-8) |
 |
| Description： |
Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders.
IC50 value:
Target: Factor Xa
Rivaroxaban (Xarelto; BAY 59-7939) inhibits clot-associated,free FXa activity,and prothrombinase activity, in addition, it reduces thrombin generation. Rivaroxaban (Xarelto; BAY 59-7939) is useful for antithrombotic agent.
|
| Product No. |
KT20526 |
| Product Name |
Rivaroxaban |
| Synonyms |
|
| Formal Name |
|
| CAS Number |
366789-02-8 |
| Molecular Formula |
C19H18ClN3O5S |
| Formula Weight |
435.88 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
5-R-Rivaroxaban 5-R-Rivaroxaban is (R) enantiomer of Rivaroxaban. Rivaroxaban (Xarelto; BAY 59-7939) is a novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders.
IC50 value:
Target: Factor Xa
Rivaroxaban (Xarelto; BAY 59-7939) inhibits clot-associated,free FXa activity,and prothrombinase activity, in addition, it reduces thrombin generation. Rivaroxaban (Xarelto; BAY 59-7939) is useful for antithrombotic agent.
|
|
